SMPD2 and Alzheimer disease: Since the changes in SMase activities can influence SP metabolism and influence AD pathology (Jana and Pahan, 2010; Lee et al., 2014; Dinkins et al., 2016), we measured both aSMase and nSMase activities in CSF from CH clinical subgroups and AD.